SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo Inc. is seeing heightened market attention following reports that the Trump administration selected the company for a federal initiative aimed at accelerating the development of nuclear reactors for AI data centers. While some community members remain skeptical due to previous missed deadlines and insider selling, others see the government partnership as a vital catalyst to de-risk the company's timeline and support long-term commercialization.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is facing heightened investor scrutiny as the broader small modular reactor (SMR) sector contends with cooling sentiment and skepticism regarding commercial deployment timelines. While the community remains divided over the company's long-term utility in powering AI data centers, investors are closely monitoring for any official contract announcements or updates on strategic partnerships to break the current period of stagnation.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as investors focus on the potential for European regulatory approval of Miplyffa, with the community actively tracking the upcoming EMA plenary agenda for a breakthrough. Sentiment is bolstered by bullish analyst upgrades and institutional interest, while discussions center on the stock's tight float and the strategic value of the drug's exclusivity protections.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is attracting significant attention as investors weigh its high-margin AI-powered advertising growth against recent price volatility and analyst commentary on e-commerce pixel adoption. The community is actively debating whether current pullbacks represent a major buying opportunity ahead of upcoming earnings or if the stock faces broader sector-wide pressure.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is capturing significant investor attention as its critical role in powering AI data centers via a major natural gas infrastructure deal with Microsoft intersects with heightened geopolitical volatility. The community remains focused on the company's ability to maintain strong shareholder returns and dividend growth while navigating Middle East supply disruptions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is currently trending as investors anticipate imminent Phase 3 IZAR-1 clinical trial results, which management previously signaled would be ready within the month. The community is actively discussing the stock's potential as a buyout candidate and the clinical data's ability to trigger a significant re-rating, while expressing frustration over recent price volatility and insider sales ahead of the expected catalyst.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors react to the company securing UAE marketing authorization for its lead immunotherapy, Anktiva, across both bladder and lung cancer indications, while the community remains hyper-focused on the company's global expansion strategy and the upcoming second-quarter earnings report. Despite this regulatory milestone, active discussion centers on the stock's high short interest and market volatility, with many investors debating whether current price action reflects a potential undervaluation or ongoing institutional suppression.

ProShares Trust - ProShares UltraPro QQQ 3x Shares

ProShares UltraPro QQQ

TQQQ is trending as investors weigh high-growth AI and semiconductor optimism against ongoing geopolitical volatility and concerns over persistent inflation. The community remains sharply divided between those using leveraged strategies to capitalize on tech momentum and those bracing for potential market pullbacks due to interest rate uncertainties and macro-level instability.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending as investors weigh significant contract wins against the backdrop of global energy instability and a cooling in regional geopolitical premiums. The community is actively discussing the impact of the pending Valaris merger on long-term valuation, the implications of fluctuating offshore day rates, and the company's progress in aggressively reducing its debt load.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is trending as investors react to the company's recent acquisition of Siemens turbines, fueling speculation that a major hyperscale anchor tenant announcement is imminent. Community sentiment is polarized between those betting on an epic short squeeze driven by performance-based executive incentives and skeptics wary of dilution and the lack of confirmed contracts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biofrontera AG engages in the research, development, and marketing of dermatological products. Its products include Ameluz, BF-RhodolesXepi and Belixos. The company was founded by Hermann Lübbert in 1997 and is headquartered in Leverkusen, Germany.

Biofrontera AG - ADR

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$2.48
Prev Close	$2.43
Open	$2.58
Dividend Yield	N/A
50-Day Moving Average	$2.35
Beta	0.56
Avg. Volume	1,597.17
PE Ratio	5.41

52-Week High	$6.89
52-Week Low	$1.50
Market Capitalization	$70.33M
EPS (Annual)	-$0.353
Price to Book	3.16
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info